Legal Opinion
Ranbaxy Laboratories, Ltd. v. Burwell
District Court, District of Columbia
Decided March 11, 2015No. Civil Action No. 2014-1923PublishedCited by 5 opinions
1Opinion of the Court
MEMORANDUM OPINION
BERYL A. HOWELL, United States District Judge
A subsidiary of the plaintiffs, Ranbaxy Laboratories, Ltd. and Ranbaxy, Inc. (collectively, “Ranbaxy” or the “plaintiffs”), paid, in 2013, what was then the “largest drug safety settlement” in history, amounting to $500 million, in connection with criminal charges for falsifying data and manufacturing adulterated drugs at two of its facilities in India. U.S. Dep’t of Justice, “Generic Drug Manufacturer Ran- baxy Pleads Guilty and Agrees to Pay $500 Million to Resolve False Claims Allegations, cGMP Violations and False Statements…
2Cases cited72 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Lujan v. Defenders of WildlifeSupreme Court of the United States · 1992
- Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
- Motor Vehicle Mfrs. Assn. of United States, Inc. v. State Farm Mut. Automobile Ins. Co.Supreme Court of the United States · 1983
- Citizens to Preserve Overton Park, Inc. v. VolpeSupreme Court of the United States · 1971
67 more not listed; retrieve them via the Exa API.
3Cited by5 opinions
- American Sales Co. v. AstraZeneca LPCourt of Appeals for the First Circuit · 2016
- In re Nexium (Esomeprazole) Antitrust LitigationDistrict Court, D. Massachusetts · 2015
- In re: Nexium Antitrust v.Court of Appeals for the First Circuit · 2016
- Meijer, Inc. v. Ranbaxy Inc.District Court, D. Massachusetts · 2019
- Voyageur Outward Bound School v. United States of AmericaDistrict Court, District of Columbia · 2020